ArticlebioRxiv : the preprint server for biology2026
Biochemical Functions of the Membrane-Binding Domain of CARMIL.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Actin assembly at membranes is often associated with proteins with domains that bind and regulate heterodimeric actin capping protein (CP). CP-binding domains can target CP to the membrane and activate CP by promoting dissociation of its stoichiometric inhibitor V-1. The capping protein binding region (CBR) of CARMIL includes a CPI motif and a CSI motif, followed by a membrane binding (MB) domain. The MB domain is necessary for the function of CARMIL in cells, and it is sufficient for targeting GFP to the plasma membrane of cells. Here, we investigated the mechanism and significance of the relationship of the MB domain to CP activity, including capping of actin filament barbed ends and promotion of Arp2/3-nucleated actin assembly. We found that the MB domain is able to bind to lipid-coated beads, bringing the CPI and CSI motifs to the bead, and thus activating CP to promote Arp2/3-based actin assembly. In addition, we discovered that the MB domain can dissociate from the lipid membrane once CP binds; this observation may help account for the long-standing quandary as to how activated CP is released from the membrane and how CP functions to activate Arp2/3-mediated actin assembly near the membrane. We also report that the MB domain released from the membrane enhances the ability of the CPI and CSI domains to activate CP. Thus, the CARMIL MB domain has multiple biochemical functions regulating actin assembly at a membrane. First, it can target CARMIL, CP, and barbed ends to the plasma membrane. Second, the MB domain can leave the membrane, and this promotes the uncapping of capped barbed ends and activates soluble CP, with greater ability than seen with the membrane-attached state.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.